Probiotics are known to promote human health either precautionary in healthy individuals or therapeutically in patients suffering from certain ailments. Although this knowledge was empirical in past tomes, modern science has already verified it and expanded it to new limits. These microorganisms can be found in nature in various foods such as dairy products or in supplements formulated for clinical or preventive use. The current review examines the different mechanisms of action of the probiotic strains and how they interact with the organism of the host. Emphasis is put on the clinical therapeutic use of these beneficial microorganisms in various clinical conditions of the human gastrointestinal tract. Diseases of the gastrointestinal tract and particularly any malfunction and inflammation of the intestines seriously compromise the health of the whole organism. The interaction between the probiotic strains and the host’s microbiota can alleviate the clinical signs and symptoms while in some cases, in due course, it can intervene in the underlying pathology. Various safety issues of the use of probiotics are also discussed.

Hospital-acquired infections are a significant concern in healthcare settings, leading to patient safety risks, increased morbidity and mortality, and financial burdens. Hand hygiene is crucial in preventing the spread of bacteria in hospitals and communities. Manual hand sanitizer dispensers can harbor presumptive pathogenic bacteria and act as fomites for bacterial transmission. This study aimed to assess the microbial contamination of manual hand sanitizer dispensers in a hospital setting and to study their antibiotic resistance profiles. Samples were collected using sterile cotton swabs and then inoculated into brain heart infusion broth. Subsequent subcultures were performed on both blood and MacConkey agar. The isolates were then identified using the Bruker MALDI Biotyper (Bruker Daltonik, Bremen, Germany) to the species level. Sampling was conducted in various wards and in the hospital and the University areas on dispenser levers and nozzle areas. The results showed that all samples yielded one or more bacterial species. Bacterial isolates identified belonged to species commonly found on the skin microflora and some Gram-negative enteric bacilli. Higher colonization was observed on the dispenser lever. Among Gram⁺ microorganisms, most bacterial species were shown to be sensitive to β-lactams, with the exception of Staphylococcus spp., resistant to AMP (Ampicillin) and Penicillin. However, no Methicillin resistant isolates were detected. Gram⁻ microorganisms such as Pseudomonas luteola were shown to be sensitive to all tested antibiotics, while Pantoea agglomerans was shown to be resistant to AMC (amoxicillin–clavulanic acid). Rifampicin tested only against Bacilli showed resistance. Based on the findings, it is recommended to implement systematic cleaning and proper maintenance of manual dispenser areas or to use automated dispensers to reduce hand contact and minimize microbial contamination. Monitoring the presence of microorganisms in hand sanitizing gels and dispensers is an essential infection control strategy.

Background/Objectives: Antimicrobial resistance, an evolutionarily entrenched microbial capacity amplified by extensive antibiotic exposure, has increased the burden of difficult-to-treat infections caused by priority pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus. In this study, we assessed whether phytochemical-rich extracts from fully ripe Rosa canina pseudo-fruits (WF) and fully developed Colchicum autumnale flowers (CA) can provide combined antioxidant, antibacterial, and antibiofilm effects against multidrug-resistant clinical isolates. Methods: Plant materials were processed using seven extraction systems spanning non-polar to polar conditions (n-hexane, ethyl acetate, n-butanol, aqueous, 40% ethanol, 60% ethanol, and enzyme-assisted hydrolysis). Fractions were quantified for total phenolics, flavonoids, and tannins, evaluated for antioxidant capacity (DPPH and FRAP), tested for antibacterial activity (disc diffusion and MIC/MBC), and assessed for inhibition of early biofilm attachment. Differences among extraction methods and fractions were analyzed using standard comparative statistics (group comparisons across solvents/fractions), and relationships between chemical composition and bioactivity were examined using correlation-based analysis. Results: Extraction strategy emerged as the main determinant of bioactivity across endpoints. The WFE/ENZ fraction maximized phytochemical recovery (TPC 203.34 ± 11.55 mg GAE/g DW; TFC 35.67 ± 3.06 mg QE/g DW; TTC 53.00 ± 2.65 mg TAE/g DW) and showed strong antioxidant performance (DPPH IC₅₀ 33.60 ± 0.02 μg/mL; FRAP A₇₀₀ 1.90 ± 0.010 at 250 μg/mL). Antibacterial effects were strongest in polar fractions, particularly hydroethanolic and enzyme-assisted extracts, while n-hexane fractions were consistently weakest. Across eight clinical isolates and three reference strains, MIC values ranged from 0.04875 to 6.25 mg/mL for WF extracts and 0.0975–12.5 mg/mL for CA extracts. In the biofilm model, suppression of early attachment was most consistent for CAE/E60–ENZ and WFE/E40–E60–ENZ fractions. Conclusions: Correlation analysis indicated that antibacterial potency aligned primarily with flavonoid levels in R. canina pseudo-fruits and with tannin content in C. autumnale material. Overall, these results support hydroethanolic and enzyme-assisted extraction as rational strategies to enrich polyphenol-dense fractions with convergent antioxidant, antibacterial, and antibiofilm activity, reinforcing plant-derived matrices as a structured discovery space for developing complementary antimicrobial solutions beyond conventional antibiotics. Notably, this is among the first studies to evaluate the antibacterial potential of C. autumnale plant material in this context and to comprehensively assess R. canina pseudo-fruit extracts against multidrug-resistant clinical.